This reference book compiles the recent advances in computational and experimental modelling to screen and manage Alzheimer’s disease. It covers basic etiopathology and various in vitro and in vivo strategies of disease intervention.

The book discusses how computer-aided drug design approaches reduce costs and increase biological test efficiency. It reviews the screening for anti-Alzheimer drugs and biomarker analysis of disease inhibitors.

The book also explores mechanistic aspects of neurodegeneration and the use of natural products as therapeutics for Alzheimer’s disease. Key features:Elaborates on the computational modelling of protein target inhibitors as anti-Alzheimer’s agentsExplains the role of phytomolecules and natural products in Alzheimer’s therapyReviews preclinical ways to assess drugs focusing on Alzheimer’s diseaseCovers biomarker analysis for Alzheimer’s diseaseDiscusses the onset and progression of Alzheimer’s diseaseThe book is meant for professionals, researchers, and students of neuroscience, psychology, and computational neurosciences.

. .